Procter & Gamble Forecast, price target & analysts
Procter & Gamble Target price 2026 - Analyst rating & recommendation
Procter & Gamble Classifications & Recommendation
Procter & Gamble Price Target
| Target Price | $163.20 |
| Price | $146.23 |
| Potential | 11.61% |
| Number of Estimates | 30 |
| 30 Analysts have issued a price target Procter & Gamble 2027 . The average Procter & Gamble target price is $163.20. This is 11.61% higher than the current stock price. The highest price target is $195.30 33.56% , the lowest is $144.43 1.23% . | |
| A rating was issued by 37 analysts: 19 Analysts recommend Procter & Gamble to buy, 17 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Procter & Gamble stock has an average upside potential 2027 of 11.61% . Most analysts recommend the Procter & Gamble stock at Purchase. |
Sales and Margin forecast 2027, 2028 to 2033
30 Analysts have issued a sales forecast Procter & Gamble 2027 . The average Procter & Gamble sales estimate is
This results in the following potential growth metrics:
26 Analysts have issued an Procter & Gamble EBITDA forecast 2027. The average Procter & Gamble EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
32 Procter & Gamble Analysts have issued a net profit forecast 2027. The average Procter & Gamble net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2033
32 Analysts have issued a Procter & Gamble forecast for earnings per share. The average Procter & Gamble EPS is
This results in the following potential growth metrics and future valuations:
Procter & Gamble...
Current Procter & Gamble Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Argus Research |
Buy
➜
Hold
|
Downgrade | Aug 07 2026 |
| HSBC |
Buy
➜
Hold
|
Downgrade | Jul 30 2026 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | Jul 30 2026 |
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Jul 21 2026 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Jul 16 2026 |
| B of A Securities |
Buy
➜
Buy
|
Unchanged | Jul 10 2026 |
| Bernstein |
➜
Market Perform
|
Initiated | Jun 11 2026 |
| Analyst Rating | Date |
|---|---|
|
Downgrade
Argus Research:
Buy
➜
Hold
|
Aug 07 2026 |
|
Downgrade
HSBC:
Buy
➜
Hold
|
Jul 30 2026 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Jul 30 2026 |
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Jul 21 2026 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Jul 16 2026 |
|
Unchanged
B of A Securities:
Buy
➜
Buy
|
Jul 10 2026 |
|
Initiated
Bernstein:
➜
Market Perform
|
Jun 11 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
